REGULATION OF CYCLOOXYGENASE GENES IN DEVELOPING LUNG
肺发育中环加氧酶基因的调控
基本信息
- 批准号:2231527
- 负责人:
- 金额:$ 20.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-12-01 至 1998-11-30
- 项目状态:已结题
- 来源:
- 关键词:SDS polyacrylamide gel electrophoresis embryo /fetus cell /tissue gene expression growth /development hormone regulation /control mechanism immunocytochemistry in situ hybridization lung messenger RNA molecular cloning newborn animals northern blottings oxygen tension oxygenases physiologic stressor polymerase chain reaction prostacyclins prostaglandin E protein biosynthesis protein degradation radioimmunoassay sheep vascular endothelium vascular smooth muscle western blottings
项目摘要
Prostacyclin (PGI2) and prostaglandin E2 (PGE2) are critical mediators
of vasomotor tone, airway reactivity, and surfactant synthesis in the
developing lung. They are produced primarily in vascular cells by
cyclooxygenase (COX), which exists in two isoforms, COX-1 and COX-2. We
have demonstrated O2 modulation of PGI2 and PGE2 synthesis in ovine fetal
and newborn intrapulmonary arteries (PA), with hypoxia causing decreased
synthesis in fetal PA and increased synthesis in newborn PA. We have also
demonstrated a 32-fold maturational rise in PGI2 synthesis. Both the O2-
and age-associated alterations in synthesis are related to changes in COX
protein expression. The OVERALL OBJECTIVE of this proposal is to
determine the molecular mechanisms by which COX gene expression in
pulmonary vascular cells is modified by changes in O2 and by maturation,
focusing the latter studies on modulation by hormonal factors and shear
stress. Aim No. 1 is to determine the effects of O2 on COX expression.
Fetal and newborn ovine PA endothelial cells (PAEC) and vascular smooth
muscle (VSM) cells will be subjected to varying O2 and changes in PGI2
and PGE2 synthesis, and COX-1 and COX-2 protein and mRNA levels will be
assessed. COX protein synthesis and degradation, and COX gene
transcription and mRNA stability will also be evaluated. We hypothesize
that hypoxia downregulates COX expression in fetal cells and upregulates
expression in newborn cells. Aim No. 2 is to determine the effects of
estrogen and glucocorticoids on COX expression in fetal PAEC and VSM,
using a similar approach. Estrogen enhances and glucocorticoids attenuate
PGI2 synthesis in other cell types, and estrogen levels rise in the fetus
and cortisol levels fall postnatally as PA COX protein increases. As
such, we hypothesize that COX expression is upregulated by estrogen and
downregulated by glucocorticoids. Aim No. 3 is to determine if COX
expression is upregulated by prolonged shear stress, which increases PG2
synthesis in nonpulmonary endothelium. Fetal PAEC will be subjected to
24 h of shear, and changes in COX function, protein and mRNA expression
will be assessed. Aim No. 4 is to test the hypothesis that there is cell-
specific developmental regulation of COX expression. Immunohistochemical
analyses and in situ hybridization for COX-1 and COX-2 will be performed
in fetal, newborn and adult ovine lung. By revealing the molecular
processes modulating PGI2 and PGE2 synthesis in the developing lung,
these studies will increase our understanding of the mechanisms
underlying successful pulmonary vascular, airway and alveolar function
in the neonatal period.
前列环蛋白(PGI2)和前列腺素E2(PGE2)是关键介体
血管舒张张张,气道反应性和表面活性剂合成
发育肺部。它们主要由
环氧合酶(COX)存在于两个同工型COX-1和COX-2中。我们
已经证明了卵子胎儿中PGI2和PGE2合成的O2调制
和新生儿肺内动脉(PA),缺氧降低
胎儿PA的合成和新生儿PA中的合成增加。我们也有
在PGI2合成中显示出32倍的成熟升高。两个O2-
合成中与年龄相关的变化与Cox的变化有关
蛋白表达。该提议的总体目的是
确定Cox基因表达在的分子机制
肺血管细胞是通过O2的变化和成熟的变化来改变的
将后者的研究集中在荷尔蒙因子和剪切的调制上
压力。目标1是确定O2对COX表达的影响。
胎儿和新生儿椭圆形PA内皮细胞(PAEC)和血管光滑
肌肉(VSM)细胞将受到不同的O2和PGI2的变化。
PGE2合成,Cox-1和Cox-2蛋白和mRNA水平将是
评估。 Cox蛋白质合成和降解和Cox基因
也将评估转录和mRNA稳定性。我们假设
缺氧下调胎儿细胞中的Cox表达并上调
在新生细胞中的表达。目标2是确定
胎儿PAEC和VSM中COX表达的雌激素和糖皮质激素,
使用类似的方法。雌激素增强和糖皮质激素减弱
其他细胞类型中的PGI2合成,胎儿的雌激素水平上升
随着PA COX蛋白的增加,皮质醇水平在产后下降。作为
这样,我们假设Cox表达被雌激素和
被糖皮质激素下调。目标3是确定Cox是否
表达被延长的剪切应力上调,这增加了PG2
非肺内皮的合成。胎儿PAEC将受到
剪切24小时,COX功能,蛋白质和mRNA表达的变化
将被评估。目标第4号是测试有细胞的假设
COX表达的特定发育调节。免疫组织化学
将进行COX-1和COX-2的分析和原位杂交
在胎儿,新生儿和成年卵子肺中。通过揭示分子
在发育中的肺中调节PGI2和PGE2合成的过程,
这些研究将增加我们对机制的理解
潜在的成功肺血管,气道和肺泡功能
在新生儿时期。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PHILIP W SHAUL其他文献
PHILIP W SHAUL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PHILIP W SHAUL', 18)}}的其他基金
Unraveling ApoE4 Promotion of Cardiometabolic Disease
揭示 ApoE4 对心血管代谢疾病的促进作用
- 批准号:
10402846 - 财政年份:2020
- 资助金额:
$ 20.14万 - 项目类别:
Unraveling ApoE4 Promotion of Cardiometabolic Disease
揭示 ApoE4 对心血管代谢疾病的促进作用
- 批准号:
10620700 - 财政年份:2020
- 资助金额:
$ 20.14万 - 项目类别:
Unraveling ApoE4 Promotion of Cardiometabolic Disease
揭示 ApoE4 对心血管代谢疾病的促进作用
- 批准号:
10283188 - 财政年份:2020
- 资助金额:
$ 20.14万 - 项目类别:
Unraveling ApoE4 Promotion of Cardiometabolic Disease
揭示 ApoE4 对心血管代谢疾病的促进作用
- 批准号:
10192811 - 财政年份:2020
- 资助金额:
$ 20.14万 - 项目类别:
Endothelial Estrogen Receptor Alpha and Cardiometabolic Disease
内皮雌激素受体α与心脏代谢疾病
- 批准号:
10394874 - 财政年份:2019
- 资助金额:
$ 20.14万 - 项目类别:
Endothelial Estrogen Receptor Alpha and Cardiometabolic Disease
内皮雌激素受体α与心脏代谢疾病
- 批准号:
9816320 - 财政年份:2019
- 资助金额:
$ 20.14万 - 项目类别:
Dichotomous Role of Endothelial SR-BI in Atherosclerosis
内皮 SR-BI 在动脉粥样硬化中的二分作用
- 批准号:
9235634 - 财政年份:2016
- 资助金额:
$ 20.14万 - 项目类别:
Fc gamma RIIB and Inflammation-Related Vascular Disease
Fc gamma RIIB 和炎症相关血管疾病
- 批准号:
8502166 - 财政年份:2013
- 资助金额:
$ 20.14万 - 项目类别:
相似海外基金
Role of Sterols & Insulin in Cardiac Autonomic Response
甾醇的作用
- 批准号:
7125441 - 财政年份:2004
- 资助金额:
$ 20.14万 - 项目类别:
The role of VEGF isoforms in tumor angiogenesis
VEGF亚型在肿瘤血管生成中的作用
- 批准号:
6912661 - 财政年份:2004
- 资助金额:
$ 20.14万 - 项目类别:
Role of Sterols & Insulin in Cardiac Autonomic Response
甾醇的作用
- 批准号:
6928644 - 财政年份:2004
- 资助金额:
$ 20.14万 - 项目类别:
Poxvirus adverse effects on cardiac cells and the heart
痘病毒对心肌细胞和心脏的不利影响
- 批准号:
6756318 - 财政年份:2004
- 资助金额:
$ 20.14万 - 项目类别:
Poxvirus adverse effects on cardiac cells and the heart
痘病毒对心肌细胞和心脏的不利影响
- 批准号:
6877102 - 财政年份:2004
- 资助金额:
$ 20.14万 - 项目类别: